Of note, CD4+ T cells from HNSCC patients showed a significantly lower PD-1 expression in cultures with a platelet:PBMC ratio of 1:1 and 100:1 after 72 h compared to healthy donors. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.